previous section
next sub-section

A

A-Team, product placement in, 374

nicotine, 95 -96

via mouth, 78

acetaldehyde, filter for, 154

acetylcholine, nicotine effects on, 86

acidity

Food and Drug Administration, 94

nicotine

—absorption, 67 , 79 , 80

—delivery, 93 , 96

—extractable, 79

See also Extractable nicotine; Nicotine delivery

acrolein, filter for, 154

actron filter, 279 -280

ACVA Atlantic

CTR special project, 328

indoor air quality, 411 -412

See also Healthy Buildings International

Ad Hoc Committee, role in selecting special projects, 290

addiction

CTR not interested in studying, 304 -305

definition, 58

DSM III listing negative development for industry, 353

extent of nicotine addiction, 59

Food and Drug Administration, 102 , 103

habit, 80 , 81

necessary dose of nicotine, 84 , 102

nicotine, 15 , 68 , 69 , 74 , 80

Nicotine Addiction (Surgeon General's report). See Surgeon General's report, Nicotine Addiction

political problem, 249

procedures so companies could deny, 439

Sandefur, Thomas, comments, 105

selling nicotine, 58

Surgeon General's 1964 report, 100 -101

term, tobacco companies' reaction to, 305

tobacco companies, denials of nicotine addiction, 5

tolerance, 63 , 68

withdrawal, 64

See also Nicotine addiction; Smoker compensation

Addiction Research Foundation, CTR not interested, 304 -305

additives

allyl-isovalerate, 277

American position on disclosure of, 229

Ames test, 149 , 228 -229

anti-smoking groups' concerns, 228

benzyl acetate, 227

benzyl alcohol, 227

biological activity, effect on, 152 -153

biological activity, use of additives to reduce, 144

caffeine, 136 -137

carbon monoxide production, use of additives to affect, 19

Chemosol, 211

cinnamaldehyde, 227

cocoa, 220 -221

Committee of Council, 229

Comprehensive Smoking Education Act, 226

coumarin, 221 -223

D-Limonene, 227

destroying the data, 230

disclosure of, 225 -231

—pressure from Department of Health and Human Services, 229 -230

—pros and cons, 230 -231

eugenol, 211 , 227

extractable nicotine, use of additives to change, 81 , 83

filter characteristics, use of additives to change, 154

flavor and aroma of cigarette smoke, use of additives to change, 131

flavors, 149 , 202

food, additives in versus additives burned in tobacco, 202

glycerine (in Real cigarettes), 218

high-nicotine tobacco extract, 85

humectants, 211

independent industry panel on use of, 230 -231

inquiries, negative development for industry, 353

lawyers, 226 -228, 232 , 245

Liggett and Myers, position on disclosure of, 229

list of additives released by industry in 1994, 211 , 223 , 225 , 226 , 227 -228, 231

Lorillard, position on disclosure of, 229

menthol, 211

—in Real cigarettes, 218

mutagenicity of, 245

N-Bloctin, 147

nicotine delivery, use of additives to increase, 79

nicotine powder, 124

nothing artificial added, 218

PEI, 83

Philip Morris, position on disclosure of, 229

policy on testing of, 228 -229

polycyclic aromatic hydrocarbons, effect on, 144

potassium carbonate, 145

—use to reduce benzpyrene, 125

products liability, 230 , 232 , 233

public relations, 228 , 230 -231, 233

pure nicotine as an additive, avoiding, 85

pyridine, 227

pyrolysis, 201 , 204 , 211

R. J. Reynolds position on disclosure of, 229

regulatory aspects, 202 , 233

safrole (mace), 227

self-policing by industry, 230 -231

sidestream smoke, use of additives to reduce, 403 -404

sugar, 211

—in Real cigarettes, 218

titanium dioxide, 227

tobacco extract, 85

toxicity effected by pyrolysis of, 211

tumorgenic effects of, 19


513

types of, 202

use of, as undefendable, 231

vitamin A, 147

See also Additives Guidance Panel; and by specific additive

Additives Guidance Panel

changing role of, 232 -233

coumarin, 221 -222

diethylene glycol, 224

glycerol, 224

propylene glycol, 224

purpose of, 202 , 219

testing of additives by, excluding external testing, 232

admissibility in evidence, contract or in-house research on smoking and health, 275

advertising

brand advertising used to send political message, 191

Camel cigarettes, 28

countering health messages, 187 -193

editorial content, use of advertising dollars to influence, 357 , 358

First Amendment, 261 -262

health-image cigarettes, 26

healthier cigarettes, 28

Kent cigarettes, 29

Kool cigarettes, 28 , 29 , 387

less irritating cigarettes, 28

Lucky Strike cigarettes, 28

motion picture trailers, 287

nicotine delivery, 29

Old Gold cigarettes, 28

passive smoking and lung cancer, use of advertising to attack evidence on, 414

physician endorsements, 28

revenue losses threatened by anti-smoking legislation, 358

Viceroy cigarettes, 28 , 29

voluntary agreement between industry and Federal Trade Commission, 28

advertising restrictions

benefits to industry of broadcast advertising ban, 256 , 258

dealing with, 137 , 408

Federal Trade Commission, 260 -261

money lost by advertisers if advertising regulated, 358

product placement to circumvent television advertising restrictions, 365 , 368 -369

smokeless tobacco, efforts to prevent AMA from supporting, 312

Surgeon General's 1964 report, response to, 175

AFP. See Associated Film Promotion

agricultural chemical study group, 209

agriculture department. See Department of Agriculture

air pollution

CTR special report, 333

environmental tobacco smoke, 22 , 393 -394

See also Environmental tobacco smoke; Passive smoking; Sidestream smoke

ALEPH foundation, 321

All the Marbles, product placement in, 390

Allied Dunbar (UK), and BAT, 5

allyl-isovalerate, additives, 227

Alta Marea Productions, solicited product placement, 367

AMA-ERF. See American Medical Association; American Medical Association Education and Research Fund

AMC Theatres, Kool Jazz advertisements in, 387

American Brands

Addiction Research Foundation, 304

Council for Tobacco Research, 286

American Cancer Society

environmental tobacco smoke, 351

industry efforts to keep corporations from cooperating with, 355

nicotine-blocking agents, 99

Proposition 5 , 423 , 424

responding to, 73

"safe" cigarette research, 53

Surgeon General's 1964 report, anticipated response of, 51

threat to industry, 247

Tobacco Institute use of American Cancer Society study on passive smoking and lung cancer, 351 , 414

American Chemosol Corporation, 212 . See also Chemosol

American Heart Association

environmental tobacco smoke, 384

"safe" cigarette research by, 53

Surgeon General's 1964 report, anticipated reaction of, 51

American Legislative Exchange Council, Tobacco Institute contributions, 385

American Lung Association

Huber, Gary, presentation, 394

Sterling, Theodor, presentation, 297

American Medical Association

creating controversy about smoking and health, 181

Education and Research Fund report, as negative development for industry, 353

papers on Brown and Williamson documents, 11

public relations influenced by industry, 181 , 184

"safe" cigarette research, 53 , 128

Tiderock Corporation, 181 , 184

American Society of Heating, Refrigeration and Air-conditioning Engineers, presentation by Theodor Sterling, 299 -300

American Society of Legislative Clerks and Secretaries, Tobacco Institute support of, 385

American Tobacco Company

additives, position on disclosure of, 229

annual pesticide residue meeting, 209

Chemosol, 213

G-13 process to expand tobacco, 217

Tobacco Industry Research Committee, 33

workplace smoking, opposition to study of, 251

Ames test

additives, 149 , 228 -229

Additives Guidance Panel, 219

cigarette smoke, 228 -229, 302

definition, 148 , 229

lawyers, as avoiding Ames test studies, 303

league table, 20 , 148

mutagenicity of cigarettes, 20

ranking of cigarette brands, 20 , 148

sidestream smoke, 401

smoker compensation effects, 149 -150

ammonia, as affecting delivery of nicotine, 211

Amusement and Music Operators Association, Tobacco Institute support of, 386

analogues. See Nicotine analogues


514

anesthetic agent

eugenol, 211 , 219

menthol, 211

smoke easier to inhale, 219

annoyance, nonsmokers' reaction to environmental tobacco smoke, 334

annual pesticide residue meeting, 210

antifreeze, 223

anti-smoking groups, concern about additives, 228

antitrust issues

Chemosol, 285

Council for Tobacco Research, 285

fire-safe cigarette, 252 -253

laws, 284 -285

Microbiological Associates contract, 302

nicotine analogues, 286

aortic aneurysm, 19

Apocalypse Now, use of Marlboro cigarettes in, 372 -373

Ariel

Battelle Memorial Institute, 74 -77

cigarette design, 131

description, 74

Fate of Nicotine in the Body,74

idealized product, 104

less toxic cigarette, problems associated with marketing of, 440 -441

nicotine delivery device, use as, 62 , 65 , 82

patent, 75 -76

Philip Morris, 77

R. J. Reynolds, 77

"safe" cigarette research, 126

sharing information with research laboratories outside Britain, 82

status reports on, 78

arsenic

Borstal, 110

cigarette smoke, 31

asbestos

connection with smoking as negative development for tobacco industry, 353

Kent micronite filter, 29

ASHRAE. See American Society of Heating, Refrigeration and Air-conditioning Engineers

Associated Film Promotion (AFP)

audit of product placement expenses, 369 -371, 387 , 390

dissatisfaction with, 365

payment for product placements, 388 -389

product placement for Brown and Williamson, 365 -374

Sylvester Stallone, 365 -367, 370 , 371 , 373 , 389

termination of agreement with Brown and Williamson for product placements, 373 -374

See also Product placement

assumption of risk defense, in US versus UK, 340 -341

asthma, research relating to effects of environmental tobacco smoke on, 318

Atmospheric Health sciences, Domingo Aviado's consulting firm, 308

attorney-client privilege

avoidance of discovery, 241

Brown and Williamson documents, 236

definition, 236

fraud exception to, 238 -239

See also Work product rule

attorney work product. See Work product rule

attribution of statements of affiliated companies to Brown and Williamson, 6 , 267 , 273 -275

Avalon filter

description, 125

sharing information regarding, 71

Surgeon General's Advisory Committee, withholding information, 72 -73

avoidance of notes, memos, or lists, for deadwood documents, 235

avoiding disclosure of research results, 4

avoiding discovery. See Discovery


previous section
next sub-section